I agree it could test $1, but just based on financial fundamentals. Since IPO is has only achieved single digit Revenue CAGR. The level of R&D investment is too high for this performance. It might be a great company in the right tech space, but it doesn't mean it can't be overvalued. $200m Revenue at single digit growth, can't have a valuation of $1.2b.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.37 |
Change
0.030(1.28%) |
Mkt cap ! $783.8M | |||
| Open | High | Low | Value | Volume |
| $2.30 | $2.37 | $2.29 | $1.979M | 844.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2238 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 2200 | 1 |
View Market Depth
| Last trade - 16.14pm 31/07/2025 (20 minute delay) ? |
| NXL (ASX) Chart |